These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14803293)

  • 1. Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report.
    RIDER JA; SCHULMAN S; RICHTER RB; MOELLER HC; DUBOIS KP
    J Am Med Assoc; 1951 Mar; 145(13):967-72. PubMed ID: 14803293
    [No Abstract]   [Full Text] [Related]  

  • 2. Octamethyl pyrophosphoramide in the therapy of myasthenia gravis.
    GREGORY L; FUTCH ED; STONE CT
    Am J Med; 1952 Oct; 13(4):423-7. PubMed ID: 12985599
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations.
    SCHULMAN S; RIDER A; RICHTER RB
    J Am Med Assoc; 1953 Aug; 152(18):1707-11. PubMed ID: 13069246
    [No Abstract]   [Full Text] [Related]  

  • 4. Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.
    SCHULMAN S; RIDER JA; RICHTER RB
    AMA Arch Neurol Psychiatry; 1953 May; 69(5):643-6. PubMed ID: 13039628
    [No Abstract]   [Full Text] [Related]  

  • 5. The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide.
    WILSON CW; WILLIAMS JP; MILLER DH
    Ann Intern Med; 1952 Sep; 37(3):574-9. PubMed ID: 12976955
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
    OSSERMAN KE; KAPLAN LI
    Ann Intern Med; 1954 Jul; 41(1):108-11. PubMed ID: 13171793
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of myasthenia gravis with octamethyl pyrophosphoramide (peptox III): a preliminary report.
    RIDER JA; SCHULMAN S; RICHTER R; MOELLER HC; DUBOIS KP
    AMA Arch Neurol Psychiatry; 1951 Aug; 66(2):111-2. PubMed ID: 14846437
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of tolerance in the rat to octamethyl pyrophosphoramide.
    RIDER JA; ELLINWOOD LE; COON JM
    Proc Soc Exp Biol Med; 1952 Nov; 81(2):455-9. PubMed ID: 13027338
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF CHLORCYCLIZINE ON THE TOXICITY AND METABOLISM OF OCTAMETHYL PYROPHOSPHORAMIDE.
    MCPHILLIPS JJ
    Toxicol Appl Pharmacol; 1965 Jan; 7():64-70. PubMed ID: 14256604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myasthenia gravis therapy with SK 52].
    GIESEN J; KOELZER PP
    Med Klin; 1950 Dec; 45(48):1530-1. PubMed ID: 14805958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical examination of the therapeutic effect of some new tetraalkylpyprophosphates in myasthenia gravis pseudoparalytical].
    KOELZER PP; GIESEN J
    Ther Umsch Med Bibliogr; 1951 Feb; 7(11):172-82. PubMed ID: 14835492
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical use of hexaethyl tetraphosphate in myasthenia gravis; preliminary report.
    WESTERBERG MR; LUROS JT
    Univ Hosp Bull; 1948 Feb; 14(2):15. PubMed ID: 18859181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience in therapy of myasthenia with tetraisopropyl pyrophosphate (myastenol)].
    MOLINA ; GOTZE W
    Arztl Wochensch; 1952 Dec; 7(50):1186-7. PubMed ID: 13016389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tetra-ethyl-pyrophosphate in the treatment of myasthenia; study of blood cholinesterase].
    PASSOUANT P; LEVY A
    Rev Neurol (Paris); 1951 Jan; 84(1):88-91. PubMed ID: 14845372
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis.
    GROB D; HARVEY AM
    Bull Johns Hopkins Hosp; 1949 Jun; 84(6):532-67. PubMed ID: 18151257
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetraethyl pyrophosphate in the myasthenia gravis.
    NOVOTA OJ
    Mo Med; 1952 Feb; 49(2):133-4. PubMed ID: 14938938
    [No Abstract]   [Full Text] [Related]  

  • 17. [About the pharmacological properties of some polyalkyl phosphates and their use in myasthenia gravis].
    KOELZER P; GIESEN J
    Arztl Forsch; 1949 Jan; 3(2):13-8. PubMed ID: 18116154
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetra-ethylpyrophosphate in myasthenia gravis.
    BURGEN AS; KEELE CA; McALPINE D
    Lancet; 1948 Apr; 1(6501):519-21. PubMed ID: 18933790
    [No Abstract]   [Full Text] [Related]  

  • 19. Some physiological experiments of nature in the field of neuromuscular function; tetra-ethyl pyrophosphate in the treatment of myasthenia gravis, potassium deficiency, potassium intoxication.
    HARVEY AM
    Proc Inst Med Chic; 1948 Nov; 17(8):182-8. PubMed ID: 18892688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholinergic crisis in the treatment of myasthenia gravis].
    KUNTZ E; KAUFMANN L
    Nervenarzt; 1954 May; 25(5):209-11. PubMed ID: 13194075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.